Gaithersburg biopharma closes $105M round — and prepares for IPO ‘in near future’

The funding will support continued development of the company's treatments for cancers, metabolic and fibrosis diseases and viral infections.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 23, 2020 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news